CLL cells were incubated with selinexor for 24 h at concentrations achievable in patient plasma (50–2000 nM) [32], and then either assessed for XPO1 protein expression or co-cultured with healthy donor NK cells. Here, XPO1 is linked to B-cell chronic lymphocytic leukemia.